[go: up one dir, main page]

WO2018144093A3 - Formulations for improved skin care - Google Patents

Formulations for improved skin care Download PDF

Info

Publication number
WO2018144093A3
WO2018144093A3 PCT/US2017/059960 US2017059960W WO2018144093A3 WO 2018144093 A3 WO2018144093 A3 WO 2018144093A3 US 2017059960 W US2017059960 W US 2017059960W WO 2018144093 A3 WO2018144093 A3 WO 2018144093A3
Authority
WO
WIPO (PCT)
Prior art keywords
hyaluronic acid
collagen
formulations
skin care
improved skin
Prior art date
Application number
PCT/US2017/059960
Other languages
French (fr)
Other versions
WO2018144093A2 (en
Inventor
Mark A. Pinsky
Original Assignee
Pinsky Mark A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pinsky Mark A filed Critical Pinsky Mark A
Publication of WO2018144093A2 publication Critical patent/WO2018144093A2/en
Publication of WO2018144093A3 publication Critical patent/WO2018144093A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/001—Preparations for care of the lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Compositions and methods for administering collagen and/or hyaluronic acid to a human subject have been developed. The collagen and/or hyaluronic acid -containing lipid vesicles of the invention provide a delivery system for collagen protein and/or hyaluronic acid which significantly improve the skin condition of a human subject while eliminating problems associated with chemical and physical instability of the collagen and/or hyaluronic acid as well as associated immune responses.
PCT/US2017/059960 2016-11-03 2017-11-03 Formulations for improved skin care Ceased WO2018144093A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662416987P 2016-11-03 2016-11-03
US62/416,987 2016-11-03

Publications (2)

Publication Number Publication Date
WO2018144093A2 WO2018144093A2 (en) 2018-08-09
WO2018144093A3 true WO2018144093A3 (en) 2019-03-07

Family

ID=63040032

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/059960 Ceased WO2018144093A2 (en) 2016-11-03 2017-11-03 Formulations for improved skin care

Country Status (1)

Country Link
WO (1) WO2018144093A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210161870A1 (en) 2017-06-07 2021-06-03 Arcutis Biotherapeutics, Inc. Roflumilast formulations with an improved pharmacokinetic profile
US11129818B2 (en) 2017-06-07 2021-09-28 Arcutis Biotherapeutics, Inc. Topical roflumilast formulation having improved delivery and plasma half life
US12011437B1 (en) 2017-06-07 2024-06-18 Arcutis Biotherapeutics, Inc. Roflumilast formulations with an improved pharmacokinetic profile
US9895359B1 (en) 2017-06-07 2018-02-20 Arcutis, Inc. Inhibition of crystal growth of roflumilast
BR112020024768A8 (en) 2018-06-04 2022-12-13 Arcutis Inc METHOD FOR REDUCING THE RANGE OF CUTANEOUS PENETRATION OF ROFLUMILAST IN A PATIENT, PHARMACEUTICAL COMPOSITION COMPRISING ROFLUMILAST AND AN EMULSIFIER MIXTURE AND PHARMACEUTICAL COMPOSITION COMPRISING ROFLUMILAST AND AT LEAST ONE EMULSIFIER
CA3135835A1 (en) * 2019-04-01 2020-10-08 Geltor, Inc. Topical formulations of recombinant collagens
JP2022526434A (en) 2019-04-12 2022-05-24 ジェルター， インコーポレイテッド Recombinant elastin and its production
US11786451B2 (en) 2019-06-28 2023-10-17 The Procter & Gamble Company Skin care composition
US20200405621A1 (en) * 2019-06-28 2020-12-31 The Procter & Gamble Company Skin Care Composition
WO2021019562A2 (en) * 2019-07-26 2021-02-04 Pandorum Technologies Private Limited Bioengineered formulation, process for preparing and implementations thereof
EP3968948A1 (en) * 2019-07-29 2022-03-23 Giuliani S.p.A. Cosmetic composition with combined filler and skin regenerative effect
JP2022549216A (en) 2019-09-23 2022-11-24 ディーディーエス リサーチ インク． Lipid vesicle compositions containing penetration enhancers
CN111036156A (en) * 2020-01-14 2020-04-21 江苏罗格斯生物科技有限公司 Preparation method of green functional factor accurate control material
CN111281840B (en) * 2020-02-13 2022-03-29 广州伊尔美生物科技有限公司 Skin brightening and beautifying cream and preparation method thereof
CN114641297B (en) * 2020-05-07 2024-09-13 阿尔库缇斯生物疗法股份有限公司 Treatment of skin conditions using high krafft temperature anionic surfactants
CN111494233B (en) * 2020-06-02 2023-07-14 康珞生物科技（武汉）有限公司 Preparation method and application of collagen short peptide liposome
CN112057351B (en) * 2020-09-22 2023-01-24 西安诗莱梦特生物科技有限公司 Hyaluronic acid-hydroxypropyl methyl cellulose composite hydrogel and preparation method and application thereof
KR20230128261A (en) * 2020-09-30 2023-09-04 젤터, 인코포레이티드 Compositions Comprising Combinations of Collagen or Elastin Polypeptides and Active Ingredients and Methods of Use Thereof
CN116669696A (en) * 2020-09-30 2023-08-29 格尔托公司 Compositions comprising collagen or elastin polypeptides in combination with active ingredients and methods of use thereof
CA3162675C (en) 2020-12-04 2023-09-26 Saori Kato Topical roflumilast formulation having antifungal properties
CN114246818A (en) * 2021-03-08 2022-03-29 山东祥隆医药研究院有限公司 Essence milk with allergy preventing, moisturizing and repairing effects and preparation method thereof
WO2022204287A1 (en) * 2021-03-24 2022-09-29 Glo Pharma, Inc. Multisome lipid vesicles for delivery of cosmetic agents
CA3213099A1 (en) 2021-03-24 2022-09-29 Robert A. Love Peptides and methods for reducing skin pigmentation
CN120166935A (en) 2022-09-15 2025-06-17 阿尔库缇斯生物疗法股份有限公司 Pharmaceutical composition of roflumilast and a solvent capable of dissolving a large amount of the drug
CN116617146B (en) * 2023-05-26 2024-12-17 广东巴松那生物科技有限公司 Skin cream for repairing hormonal face and preparation method thereof
CN117137840A (en) * 2023-09-07 2023-12-01 河北纳科生物科技有限公司 Recombinant collagen white oil biphase essential oil and preparation method thereof
CN117017869B (en) * 2023-09-15 2024-01-30 名宇(广东)化妆品科技有限公司 Whitening and freckle-removing cream and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846561A (en) * 1991-02-14 1998-12-08 Baxter International Inc. Method of binding collagen recognizing substances to liposomes
US6992172B1 (en) * 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
US20100221319A1 (en) * 2005-10-03 2010-09-02 Pinsky Mark A Compositions and Methods for Improved Skin Care
KR20110036664A (en) * 2009-10-02 2011-04-08 가부시키가이샤 페이스 Cosmetic base consisting of collagen-modified liposomes and skin cosmetics containing same
CN102988200A (en) * 2012-12-10 2013-03-27 北京莱米瑞克科技发展有限公司 Liposome face-nourishing skin care product

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846561A (en) * 1991-02-14 1998-12-08 Baxter International Inc. Method of binding collagen recognizing substances to liposomes
US6992172B1 (en) * 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
US20100221319A1 (en) * 2005-10-03 2010-09-02 Pinsky Mark A Compositions and Methods for Improved Skin Care
KR20110036664A (en) * 2009-10-02 2011-04-08 가부시키가이샤 페이스 Cosmetic base consisting of collagen-modified liposomes and skin cosmetics containing same
CN102988200A (en) * 2012-12-10 2013-03-27 北京莱米瑞克科技发展有限公司 Liposome face-nourishing skin care product

Also Published As

Publication number Publication date
WO2018144093A2 (en) 2018-08-09

Similar Documents

Publication Publication Date Title
WO2018144093A3 (en) Formulations for improved skin care
AU2018240515A1 (en) Nucleic acids encoding CRISPR-associated proteins and uses thereof
WO2009086504A3 (en) Collagen formulations for improved skin care
EP4421094A3 (en) Targeted therapeutic agents and uses thereof
SG11201808019WA (en) Edaravone formulations
MX2018004616A (en) Cosmetic composition having probiotic bacteria.
MX2022009155A (en) Novel polymeric hgh prodrugs.
MY188139A (en) Sodium channel modulators for the treatment of pain
IN2014CN04187A (en)
EP4299122A3 (en) Compositions and methods for treating skin and mucous membrane diseases
MX2020005247A (en) Methods and formulations which allow the modulation of immune responses related to the administration of a biopharmaceutical drug.
CA3030422C (en) Stabilizing excipients for therapeutic protein formulations
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
MY181928A (en) Sodium channel modulators for the treatment of pain and diabetes
CL2019001586A1 (en) Insulin containing pharmaceutical compositions.
PH12018500036A1 (en) Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
WO2019098759A3 (en) Transformed human cell and use thereof
MX364800B (en) Improved long-acting tilmicosin and use thereof in the treatment of bovine respiratory disease complex (brdc) and in the dry cow period.
IN2014DN03213A (en)
MY191980A (en) Formulations containing an extract of echinacea and linoleic acid derivatives
MX2016015211A (en) Topical formulations and uses thereof.
EP4420722A3 (en) Modified fibroblast growth factors for the treatment of ocular disorders
MX379253B (en) STABILIZED OXYMETAZOLINE FORMULATIONS AND THEIR USES.
EP4403220A3 (en) Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
BR112018008769A2 (en) pharmaceutical formulations, reconstituted and lyophilized aqueous liquid formulations, syringe, method of manufacturing a pharmaceutical formulation, method for treating a disease and use of a reconstructed formulation

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17895323

Country of ref document: EP

Kind code of ref document: A2